Archive for the ‘MRK Stock’ Category

Health Care Giants Dominate List of Justice Department Fraud Settlements

Monday, November 30th, 2009

Health Care Giants Dominate List of Justice Department Fraud Settlements
AllGov – 3 hours ago
Pharmaceutical manufacturers and other health industry companies were responsible for the biggest fraud settlements obtained last year by the Department of Justice. Companies like Cephalon Inc …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Merck Declares Quarterly Dividends and Unveils New $3 Billion Share Repurchase Program

Sunday, November 29th, 2009

Merck Declares Quarterly Dividends and Unveils New $3 Billion Share Repurchase Program
Trading Markets – 12 hours ago
Nov 30, 2009 (Close-Up Media via COMTEX) — MRK — The Board of Directors of Merck & Co., Inc. has declared a quarterly dividend of $0.38 per share on the company's common stock for the first …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Merck Declares Quarterly Dividends and Unveils New $3 Billion Share Repurchase … – Trading Markets (press release)

Sunday, November 29th, 2009

Merck Declares Quarterly Dividends and Unveils New $3 Billion Share Repurchase … Trading Markets (press release) Nov 30, 2009 (Close-Up Media via COMTEX) — MRK | Quote | Chart | News | powerrating — The Board of Directors of Merck & Co., Inc. has declared a quarterly …

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

Jim Cramer’s Best Blogs – TheStreet.com

Saturday, November 28th, 2009

Jim Cramer's Best Blogs TheStreet.com … Merck ( MRK – commentary – Trade Now), Bristol-Myers (BMY – commentary – Trade Now) and Lilly (LLY – commentary – Trade Now). But there is one drug stock …

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

3 Stocks Springing Back – Motley Fool

Friday, November 27th, 2009

The Money Times 3 Stocks Springing Back Motley Fool But CAPS has a great balance of both quantitative and qualitative resources available on 5300 stocks, and even a nifty stock screening tool to help … A Big Upgrade for Amylin Pharmaceuticals Motley Fool Are These Dividends Too Good to Be True? Motley Fool all 85 news articles »

Start investing in MRK with new, one hour investment trading technologies: binary option and digital option trading platforms .

Merck to expand R&D presence in China

Friday, November 27th, 2009

Merck to expand R&D presence in China
Trading Markets – Nov 27, 2009
Nov 27, 2009 (Datamonitor via COMTEX) — MKGAY — Merck KGaA has announced plans to strengthen its global R&D capabilities of its Merck Serono division by establishing a global R&D center in …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Merck & Co., Inc. Announces Quarterly Dividends; Announces New $3 Billion Share Repurchase Program

Thursday, November 26th, 2009

Merck & Co., Inc. Announces Quarterly Dividends; Announces New $3 Billion Share Repurchase Program
Reuters Key Development – Nov 26, 2009

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Merck & Co., Inc. Announces Quarterly Dividends; Announces New $3 Billion Share Repurchase Program

Thursday, November 26th, 2009

Merck & Co., Inc. Announces Quarterly Dividends; Announces New $3 Billion Share Repurchase Program
Reuters Key Development – Nov 26, 2009

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

Karo Bio plans to enter clinical phase IIa trial with MK-6913

Thursday, November 26th, 2009

Karo Bio plans to enter clinical phase IIa trial with MK-6913
Trading Markets – 3 hours ago
Look up the PowerRating of MRK and see how it has performed over the past week as well as the current proprietary PowerRating. Nov 26, 2009 (M2 EQUITYBITES via COMTEX) — MRK — A Biotech company …

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .

KARO BIO ANNOUNCES THAT MERCK & CO., INC. PLANS TO PROCEED WITH PHASE II CLINICAL EVALUATION OF CANDIDATE COMPOUND

Thursday, November 26th, 2009

KARO BIO ANNOUNCES THAT MERCK & CO., INC. PLANS TO PROCEED WITH PHASE II CLINICAL EVALUATION OF CANDIDATE COMPOUND
Business Wire – 7 hours ago
The Swedish biotech company Karo Bio (Reuters: KARO.ST) today announced that Merck & Co., Inc., through an affiliate, plans to enter a clinical phase IIa trial with the collaboration's lead …
Merck to commence MK-6913 phase IIa efficacy trial for treatment of hot flashes/hot flushes – News-Medical.net
Karo Bio says US partner to start phase IIa trial with vasomotor symptoms drug – Trading Markets

Trade now on MRK with Binary Option Trading and Digital Option Trading platforms .